Adjuvant Therapeutics Overview
- Status
-
Out of Business
- Employees
-
1
- Latest Deal Type
-
Out of Business
Adjuvant Therapeutics General Information
Description
Developer of a cancer treatment technology designed to improve cancer treatment. The company's technology offers a system called OncO2, that increase oxygen concentrations in tumors, enabling physicians to improve the effectiveness of radiotherapy for cancer treatment.
Contact Information
Website
www.adjuvanttherapeutics.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Primary Office
- 1344 Summer Street
- Suite 311.1
- Halifax, Nova Scotia B3H 0A8
- Canada
Adjuvant Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Feb-2018 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | Completed | Startup |
Adjuvant Therapeutics Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Cliff Ansel | Chief Executive Officer |
Adjuvant Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
